Yonghua Bi | Interventional Radiology | Best Researcher Award

Prof. Yonghua Bi | Interventional Radiology | Best Researcher Award

The First Affiliated Hospital of Zhengzhou University | china

Dr. Yonghua Bi is an accomplished Associate Chief Physician at the First Affiliated Hospital of Zhengzhou University, specializing in interventional treatment of tumors and vascular diseases. With a doctoral degree from China Medical University, Dr. Bi has dedicated his career to advancing minimally invasive procedures, pioneering research, and clinical innovation in interventional medicine. His work has contributed significantly to the understanding and management of vascular disorders, particularly arterial diseases. Author of over one hundred research articles, including more than eighty SCI-indexed papers, he has also published the book Stories of Interventional Radiology. Dr. Bi holds multiple patents, reflecting his commitment to translating research into practical solutions. As an active member and leader in professional societies, he plays an influential role in advancing interventional medicine in China. Recognized for his expertise, Dr. Bi also serves as a reviewer for esteemed journals, ensuring scientific rigor and promoting research excellence in his field.

Profile

ORCID

Education

Dr. Yonghua Bi earned his doctoral degree in medicine from China Medical University, where he developed a strong academic foundation in interventional medicine and vascular disease research. His education combined rigorous clinical training with in-depth research, enabling him to bridge theory and practice effectively. During his doctoral studies, he honed specialized skills in animal modeling, imaging techniques, and minimally invasive interventions, particularly focusing on vascular pathophysiology and therapeutic approaches. This academic background equipped him with a comprehensive understanding of both fundamental mechanisms and advanced clinical applications. His education emphasized interdisciplinary collaboration, integrating radiology, surgery, and pathology to optimize patient care. Exposure to both laboratory-based investigations and real-world clinical challenges shaped his ability to design research with practical implications. This robust educational journey laid the groundwork for his future contributions to innovation in interventional radiology and propelled him into leadership roles in academic medicine, research, and professional medical organizations.

Experience

Since joining the Department of Interventional Medicine at the First Affiliated Hospital of Zhengzhou University, Dr. Yonghua Bi has built a distinguished career combining patient care, research, and academic leadership. His clinical expertise spans interventional treatment for tumors and vascular diseases, with notable achievements in managing pulmonary embolism, deep vein thrombosis, and Budd-Chiari syndrome. He has pioneered work in abdominal aortic aneurysm modeling and regression studies, influencing both research and clinical protocols. As a prolific author, Dr. Bi has published extensively, contributing evidence-based advancements to interventional medicine. His role extends to mentorship, guiding young clinicians and researchers in advanced techniques and study design. He actively participates in academic societies, serving as standing director and youth committee leader in national medical associations. In addition, his editorial responsibilities include reviewing for reputable medical journals, ensuring scientific standards. His experience reflects a commitment to improving patient outcomes while advancing the frontiers of interventional radiology.

Awards and Honors

Dr. Yonghua Bi has earned recognition for his significant contributions to interventional medicine through awards, patents, and scholarly achievements. His approval of two invention patents and three utility model patents underscores his role as an innovator translating research into clinical solutions. His extensive publication record, with over eighty SCI-indexed articles as first or corresponding author, has positioned him as a leading voice in vascular disease research. The trust placed in him as a reviewer for the Clinical Journal of Medical Officers reflects his standing in the academic community. His leadership roles as standing director of the Interventional Medicine Branch of the Bethune Medical Research Society of China and deputy director of the Youth Committee of the Henan Medical Science Popularization Society demonstrate recognition by peers for his expertise and service. These honors collectively illustrate his influence in shaping the development, dissemination, and application of interventional medical knowledge in China and beyond.

Research Focus

Dr. Yonghua Bi’s research centers on interventional treatments for tumors and vascular diseases, with a particular emphasis on arterial and venous system disorders. His work in modeling abdominal aortic aneurysms in animals has provided valuable insights into disease mechanisms and potential regression pathways. This foundational research bridges basic science with clinical applications, informing innovative treatment strategies. Clinically, he focuses on complex vascular conditions such as pulmonary embolism, deep vein thrombosis, and Budd-Chiari syndrome, developing minimally invasive interventions that improve patient outcomes. His studies often integrate imaging advancements with procedural innovation, aiming for greater precision and reduced patient risk. Dr. Bi’s dual expertise in laboratory investigation and patient-centered care enables him to design interventions grounded in scientific evidence. Beyond direct treatment, his work seeks to expand the scope of interventional radiology, fostering multidisciplinary collaboration and training future specialists to advance the field through research-driven, patient-focused medical practice.

Publications

Title: Comparison between bougie and balloon dilation of benign esophageal strictures in infants and children.
Year: 2025

Title:Small Balloon Dilation Versus Bougie Dilation Versus Large Balloon Dilation for the Treatment of Benign Esophageal Strictures in Adult Patients.
Year:2025

Title: A comparison of three kinds of balloon dilatations for patients with benign esophageal strictures.
Year:2025

Title: Clinical evaluation of oxaliplatin-loaded drug-eluting callispheres beads transarterial chemoembolization for unresectable or recurrent esophageal carcinoma.
Year:2024

Conclusion

Dr. Yonghua Bi exemplifies the integration of clinical excellence, research innovation, and academic leadership in interventional medicine. His contributions to vascular disease modeling, minimally invasive treatment strategies, and high-impact publications have advanced both scientific understanding and patient care. Through patents, professional society leadership, and active editorial work, he has influenced medical practice and fostered the next generation of specialists. His career reflects a commitment to translating rigorous research into real-world applications, improving outcomes for complex vascular and oncological conditions. With a clear vision for advancing interventional radiology, he continues to drive progress in this rapidly evolving medical specialty.

Hongjun JIN | Nuclear Medicine Molecular Imaging | Interdisciplinary Innovation Prize

Prof Dr.  Hongjun JIN | Nuclear Medicine Molecular Imaging | Interdisciplinary Innovation Prize

: Sun Yat-sen University Fifth Affiliated Hospital, china

Profile

Education

Dr. Hongjun Jin is a Principal Investigator in Nuclear Medicine and a Doctoral Supervisor of Molecular Medicine at Sun Yat-sen University. He earned his PhD in Biochemistry from Texas A&M University in 2007, following a BS in Radiochemistry from Lanzhou University in 1994 and a BMed in Chinese Medicine from Beijing University of Chinese Medicine in 1997. He completed his postdoctoral training at PNNL from 2008 to 2012 and served as a radiology instructor at Washington University in St. Louis from 2012 to 2017. Since 2017, he has led the PET and radiochemical laboratory at his institute, having been recruited through Sun Yat-sen University’s “Hundred Talents Program.”

Research and Innovations:

1) General Research Fund for National Sciences Foundation of China (NSFC), 82372004,
“F-18 labelled PET probe targeting P2X7 receptor for Evaluation of Treatment for AD”
01/01/2024-12/31/2027¥480,000,
2) Key R&D project, 0007/2022/AKP, Macao S&T Fund (FDCT),“R&D of an Integrated
Molecular probe for Targeted TNFR2 New Tumor Diagnosis and
Treatment”,01/01/2024-12/31/2027,¥2,400,000 (out of ¥120,000,000)
3) Guangdong Provincial Enterprise Joint Fund, 2021A1515220004, Guangdong Province
“PET/MRI Neuromolecular Imaging Quantitative Study of New Drug Targeting Sigma1

Research Project

  • 1) Outstanding Foreign Young Scientist Talent Program, RFIS, 82150610508 NSF-CN,
    “ Establishment and drug evaluation of acetylcholinergic and dopaminergic
    neuromolecular probes (18F VAT and 18F-DTBZ) PET brain imaging quantitative
    system for Parkinson’s disease” 2022/01-2022/12,¥400,000
  • General Research Fund for NSFC, 81871382, “F-18 labelled PET probe targeting P2X7
    receptor for early detection of AD”01/01/2019-12/31/2022¥570,000
  • SYSU “Hundred Talent “Starting Fund (Period I)” SYSU-FA10/01/2017-09/30/2022
    ¥2,500,000
  • National Key R&D Program for Precision Medicine, 2018YFC0910601 Real-time, highdimensional, multi-modality imaging co-registration and theronoastic strategies for
    oesophageal squamous-cell carcinomas10/01/2018-12/31/2020¥1,272,500 (out of
    ¥19,230,000)
  • Sun Yat-sen University Military Industry Cultivation Project, 89000-18843403 SYSU
    “Key Technologies of Molecular Imaging of Immune Dysfunction in Microgravity
    Environment”, 2019/08-2021/12¥1,890,00
  • Researchers Initiate Clinical Research Project (IIT) Award, SYSU-FAH”A single-center,
    open, prospective assessment of the diagnostic significance of 18F-FDG PET/CT
    dynamic imaging and gene sequencing in detecting metastatic lesions of non-small cell
    lung cancer”,2020/10-2021/09¥50,000
  • COVID-19 infection prevention and control emergency S&T, ZH22036302200036PWC,
    Zhuhai City”Specific Targeting S- protein of SARS-CoV-2 PET molecular imaging
    probe”2020/08-2021/09,¥70,000

Citation Index:

Google Scholar Citations: 8684 (total) 7943 (since 2020)
h-index 26(total) 20 (since 2020)
i10-index 52(total) 39(since 2020)

Publications